Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Evaluation-Guided Surveillance-Intervention With Endoscopic Selective Neck Dissection for Post-Radiotherapy N3 Nasopharyngeal Carcinoma

NCT07692906 is registered in ClinicalTrials.gov with Xuelei Ma MD as lead sponsor.

NCT NCT07692906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07692906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Evaluation-Guided Surveillance-Intervention With Endoscopic Selective Neck Dissection for Post-Radiotherapy N3 Nasopharyngeal Carcinoma
Lead sponsor
Xuelei Ma MD
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
June 30, 2035
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal cancinoma (npc)